GL1X · GenesisL1 explorer

Research workbench

Tem-1 beta-lactamase in complex with a novel, core-disrupting, allosteric inhibitor

Analyse Tem-1 beta-lactamase in complex with a novel, core-disrupting, allosteric… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1PZO
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase tem
EC
3.5.2.6
UniProt
P62593
Ligands
CBT
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase tem (EC 3.5.2.6)protein26347% helix, 17% strandP62593

Ligands and binding sites

  • CBT · N,N-bis(4-chlorobenzyl)-1H-1,2,3,4-tetraazol-5-amine · ligand · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13470.620.7842CBT

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 1PZO · TEM-1 Beta-Lactamase in Complex with a Novel, Core-Disrupting, Allosteric Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P62593 · AlphaFold monomer V2.0 prediction for beta-lactamase tem (P62593) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.